238 related articles for article (PubMed ID: 12202671)
21. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
[TBL] [Abstract][Full Text] [Related]
22. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas.
Piva R; Chiarle R; Manazza AD; Taulli R; Simmons W; Ambrogio C; D'Escamard V; Pellegrino E; Ponzetto C; Palestro G; Inghirami G
Blood; 2006 Jan; 107(2):689-97. PubMed ID: 16189272
[TBL] [Abstract][Full Text] [Related]
23. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.
Wlodarska I; De Wolf-Peeters C; Falini B; Verhoef G; Morris SW; Hagemeijer A; Van den Berghe H
Blood; 1998 Oct; 92(8):2688-95. PubMed ID: 9763551
[TBL] [Abstract][Full Text] [Related]
24. The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.
Raetz EA; Perkins SL; Carlson MA; Schooler KP; Carroll WL; Virshup DM
Am J Pathol; 2002 Sep; 161(3):875-83. PubMed ID: 12213716
[TBL] [Abstract][Full Text] [Related]
25. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.
Piva R; Pellegrino E; Mattioli M; Agnelli L; Lombardi L; Boccalatte F; Costa G; Ruggeri BA; Cheng M; Chiarle R; Palestro G; Neri A; Inghirami G
J Clin Invest; 2006 Dec; 116(12):3171-82. PubMed ID: 17111047
[TBL] [Abstract][Full Text] [Related]
26. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
27. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
[TBL] [Abstract][Full Text] [Related]
28. The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas.
Tan BT; Seo K; Warnke RA; Arber DA
J Mol Diagn; 2008 Nov; 10(6):502-12. PubMed ID: 18832464
[TBL] [Abstract][Full Text] [Related]
29. [Anaplastic large-cell lymphoma: review].
Kodet R; Mrhalová M; Krsková L; Stejskalová E
Cesk Patol; 2003 Jul; 39(3):102-14. PubMed ID: 14631806
[TBL] [Abstract][Full Text] [Related]
30. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
Ganapathi KA; Nicolae A; Egan C; Geng H; Xi L; Pack SD; McFadden JR; Raffeld M; Jaffe ES; Pittaluga S
Br J Haematol; 2024 May; 204(5):1862-1871. PubMed ID: 38613165
[TBL] [Abstract][Full Text] [Related]
31. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
[TBL] [Abstract][Full Text] [Related]
32. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
Damm-Welk C; Klapper W; Oschlies I; Gesk S; Röttgers S; Bradtke J; Siebert R; Reiter A; Woessmann W
Br J Haematol; 2009 Aug; 146(3):306-9. PubMed ID: 19545284
[TBL] [Abstract][Full Text] [Related]
33. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
Ladanyi M
Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
[TBL] [Abstract][Full Text] [Related]
34. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
Cho-Vega JH; Rassidakis GZ; Amin HM; Tsioli P; Spurgers K; Remache YK; Vega F; Goy AH; Gilles F; Medeiros LJ
Leukemia; 2004 Nov; 18(11):1872-8. PubMed ID: 15385932
[TBL] [Abstract][Full Text] [Related]
35. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
Hernández L; Beà S; Bellosillo B; Pinyol M; Falini B; Carbone A; Ott G; Rosenwald A; Fernández A; Pulford K; Mason D; Morris SW; Santos E; Campo E
Am J Pathol; 2002 Apr; 160(4):1487-94. PubMed ID: 11943732
[TBL] [Abstract][Full Text] [Related]
36. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase proteins and malignancy.
Pulford K; Morris SW; Mason DY
Curr Opin Hematol; 2001 Jul; 8(4):231-6. PubMed ID: 11561161
[TBL] [Abstract][Full Text] [Related]
38. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
Lae ME; Ahmed I; Macon WR
Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
Dalton RR; Rassidakis GZ; Atwell C; Wang S; Oyarzo MP; Medeiros LJ
Hum Pathol; 2005 Jul; 36(7):806-11. PubMed ID: 16084951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
